Max Schlaak

6PUBLICATIONS
76CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersCancer diagnosisMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

|Sep 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.

Takami Sato, Marcus O Butler, Sophie Piperno-Neumann

|Aug 25, 2025
Multimodal Approach Predicts Relapse upon Cessation of Immune Checkpoint Inhibitors in Advanced Melanoma.

Ka-Won Noh, Yuri Tolkach, Doris Helbig

|Jan 17, 2025
Discordance, accuracy and reproducibility study of pathologists' diagnosis of melanoma and melanocytic tumors.

Sarah Haggenmüller, Christoph Wies, Julia Abels

|Sep 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care.

Lukas Heinlein, Roman C Maron, Achim Hekler

|Feb 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity.

Elias A T Koch, Anne Petzold, Anja Wessely

Pageof 1

Frequent Collaborators

3 joint publications

Jessica C Hassel

3 joint publications

Friedegund Meier

3 joint publications

Dirk Schadendorf

3 joint publications

Markus V Heppt